Indaptus Therapeutics Balance Sheet Health
Financial Health criteria checks 4/6
Indaptus Therapeutics has a total shareholder equity of $9.4M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $10.9M and $1.6M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$9.74m |
| Equity | US$9.36m |
| Total liabilities | US$1.59m |
| Total assets | US$10.95m |
Recent financial health updates
Is Indaptus Therapeutics (NASDAQ:INDP) In A Good Position To Invest In Growth?
Mar 27
Is Indaptus Therapeutics (NASDAQ:INDP) In A Good Position To Deliver On Growth Plans?
Aug 15Recent updates
Is Indaptus Therapeutics (NASDAQ:INDP) In A Good Position To Invest In Growth?
Mar 27Is Indaptus Therapeutics (NASDAQ:INDP) In A Good Position To Deliver On Growth Plans?
Aug 15Indaptus Therapeutics GAAP EPS of -$0.46 beats by $0.45
Aug 08Indaptus Therapeutics: Advancing Decoy Technology To Address Cancer And Viral Indications
Sep 29Financial Position Analysis
Short Term Liabilities: INDP's short term assets ($10.3M) exceed its short term liabilities ($1.5M).
Long Term Liabilities: INDP's short term assets ($10.3M) exceed its long term liabilities ($50.7K).
Debt to Equity History and Analysis
Debt Level: INDP is debt free.
Reducing Debt: INDP has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: INDP has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: INDP has less than a year of cash runway if free cash flow continues to reduce at historical rates of 30.6% each year